Inventor · disambiguated record
Daniel Marquess
Also filed as: MARQUESS DANIEL · TURNER S DEREK
61 granted patents·5 pending applications·1,191 citations·filing 1999–2022
99Inventor score
Files withTHERAVANCE INC47MARQUESS DANIEL6THERAVANCE BIOPHARMA R&D IP LLC3UNITY BIOTECHNOLOGY INC3PRAXIS BIORESEARCH LLC2
Top patents by PatentIndex Score
66 records- 0199US6693202B1Muscarinic receptor antagonistsTHERAVANCE INC·Filed 2000·Granted Feb 17, 2004·253 cites·11 claims
- 0298US7655621B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Feb 2, 2010·26 cites·12 claims
- 0398US7649080B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Jan 19, 2010·24 cites·18 claims
- 0498US7601690B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Oct 13, 2009·25 cites·6 claims
- 0598US7553962B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Jun 30, 2009·21 cites·24 claims
- 0697US7375114B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2005·Granted May 20, 2008·41 cites·17 claims
- 0797US7341993B2Cross-linked glycopeptide—cephalosporin antibioticsTHERAVANCE INC·Filed 2005·Granted Mar 11, 2008·22 cites·2 claims
- 0897US6974797B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2002·Granted Dec 13, 2005·45 cites·25 claims
- 0996US7728127B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Jun 1, 2010·20 cites·17 claims
- 1096US7612037B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted Nov 3, 2009·18 cites·13 claims
- 1196US7332471B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2006·Granted Feb 19, 2008·21 cites·23 claims
- 1296US7279458B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2006·Granted Oct 9, 2007·50 cites·12 claims
- 1395US7067481B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2004·Granted Jun 27, 2006·41 cites·35 claims
- 1495US6878686B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2003·Granted Apr 12, 2005·49 cites·27 claims
- 1594US7759363B2Benzimidazole-carboxamide compounds as 5-HT4, receptor agonistsTHERAVANCE INC·Filed 2006·Granted Jul 20, 2010·18 cites·18 claims
- 1694US7713931B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2007·Granted May 11, 2010·7 cites·19 claims
- 1794US7396933B2Quinolinone-carboxamide compoundsTHERAVANCE INC·Filed 2005·Granted Jul 8, 2008·28 cites·13 claims
- 1894US7351704B2Indazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2005·Granted Apr 1, 2008·25 cites·19 claims
- 1994US6756400B2Sodium channel modulatorsTHERAVANCE INC·Filed 2001·Granted Jun 29, 2004·36 cites·14 claims
- 2093US7728006B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2005·Granted Jun 1, 2010·11 cites·18 claims
- 2193US7592355B2Quinolinone-carboxamide compounds as 5-HT, receptor agonistsTHERAVANCE INC·Filed 2007·Granted Sep 22, 2009·13 cites·20 claims
- 2293US7419989B2Indazole-carboxamide compoundsTHERAVANCE INC·Filed 2005·Granted Sep 2, 2008·19 cites·12 claims
- 2393US7399862B25-HT4 receptor agonist compoundsTHERAVANCE INC·Filed 2005·Granted Jul 15, 2008·26 cites·12 claims
- 2493US6995138B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2004·Granted Feb 7, 2006·34 cites·6 claims
- 2593US6646012B2Sodium channel modulatorsTHERAVANCE INC·Filed 2002·Granted Nov 11, 2003·30 cites·16 claims
- 2692US8377964B2Benzimidazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2010·Granted Feb 19, 2013·10 cites·17 claims
- 2792US7763637B2Quinolinone-carboxamide compounds as 5-HT4, receptor agonistsTHERAVANCE INC·Filed 2008·Granted Jul 27, 2010·12 cites·19 claims
- 2892US7317022B2Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonistsTHERAVANCE INC·Filed 2006·Granted Jan 8, 2008·19 cites·15 claims
- 2992US7067482B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2004·Granted Jun 27, 2006·43 cites·28 claims
- 3092US6479498B1Sodium channel drugs and usesTHERAVANCE INC·Filed 2001·Granted Nov 12, 2002·36 cites·12 claims
- 3190US7534889B25-HT4 receptor agonist compoundsTHERAVANCE INC·Filed 2008·Granted May 19, 2009·13 cites·16 claims
- 3290US7226950B2Sodium channel modulatorsTHERAVANCE INC·Filed 2006·Granted Jun 5, 2007·7 cites·11 claims
- 3390US7183323B2Sodium channel modulatorsTHERAVANCE INC·Filed 2004·Granted Feb 27, 2007·20 cites·5 claims
- 3488US8575192B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2012·Granted Nov 5, 2013·6 cites·18 claims
- 3588US7498442B2Quinolinone-carboxamide compoundsTHERAVANCE INC·Filed 2008·Granted Mar 3, 2009·10 cites·10 claims
- 3688US7446114B2Quinolinone compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2006·Granted Nov 4, 2008·10 cites·15 claims
- 3787US8962653B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2013·Granted Feb 24, 2015·5 cites·11 claims
- 3886US11129838B2Methods of inhibiting pathological angiogenesisUNITY BIOTECHNOLOGY INC·Filed 2020·Granted Sep 28, 2021·2 cites·28 claims
- 3986US8163920B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2010·Granted Apr 24, 2012·5 cites·4 claims
- 4085US7875629B2Quinolinone compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2008·Granted Jan 25, 2011·6 cites·11 claims
- 4185US7405199B2Cross-linked glycopeptide-cephalosporin antibioticsTHERAVANCE INC·Filed 2005·Granted Jul 29, 2008·5 cites·6 claims
- 4285US7132422B2Sodium channel modulatorsTHERAVANCE INC·Filed 2005·Granted Nov 7, 2006·2 cites·11 claims
- 4384US10662146B2Prodrugs of fencamfaminePRAXIS BIORESEARCH LLC·Filed 2016·Granted May 26, 2020·2 cites·16 claims
- 4484US10588916B2Technology to inhibit vascular changes that lead to vision loss in the eyeUNITY BIOTECHNOLOGY INC·Filed 2018·Granted Mar 17, 2020·2 cites·5 claims
- 4584US8309575B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2010·Granted Nov 13, 2012·5 cites·5 claims
- 4683US9353106B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2015·Granted May 31, 2016·2 cites·9 claims
- 4783US7871997B2Cephalosporin compoundsTHERAVANCE INC·Filed 2007·Granted Jan 18, 2011·1 cites·11 claims
- 4882US7772239B2Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2007·Granted Aug 10, 2010·4 cites·16 claims
- 4982US7329752B2Carbamate compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2006·Granted Feb 12, 2008·4 cites·13 claims
- 5081US9873692B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jan 23, 2018·1 cites·2 claims
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel Marquess files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →